Results 231 to 240 of about 3,030,015 (277)

Ruxolitinib targets JAK-STAT signaling to modulate neutrophil activation in refractory macrophage activation syndrome.

open access: yesBlood
Ma Y   +20 more
europepmc   +1 more source

Macrophage Activation Syndrome [PDF]

open access: yesHematology/Oncology Clinics of North America, 2015
Macrophage activation syndrome (MAS) is a potentially life-threatening complication of rheumatic disorders that occurs most commonly in systemic juvenile idiopathic arthritis.
Alberto Martini   +2 more
exaly   +8 more sources

MACROPHAGE ACTIVATION SYNDROME

Journal of Clinical Gastroenterology, 2011
We recently treated a patient with adult-onset Still's disease who developed macrophage activation syndrome (MAS) secondary to disseminated histoplasmosis while being treated with adalimumab. The gastroenterology service was consulted early, before diagnosis, as the patient presented with elevated liver enzymes and disseminated intravascular ...
Bijal A, Jayakar, Philip J, Hashkes
openaire   +3 more sources

Macrophage Activation Syndrome

Arthritis & Rheumatology
Macrophage activation syndrome (MAS) is a state of immune hyperactivation that can result in life‐threatening multisystem end‐organ dysfunction. Often termed a “cytokine storm,” MAS occurs among the rheumatic diseases most typically in Still's disease but also in systemic lupus erythematosus and Kawasaki disease.
Sean Deane, M. Eric Gershwin
  +6 more sources

The genetics of macrophage activation syndrome

Genes & Immunity, 2020
Macrophage activation syndrome (MAS), or secondary hemophagocytic lymphohistiocytosis (HLH), is a cytokine storm syndrome associated with multi-organ system dysfunction and high mortality rates. Laboratory and clinical features resemble primary HLH, which arises in infancy (1 in 50,000 live births) from homozygous mutations in various genes critical to
Grant S, Schulert, Randy Q, Cron
openaire   +2 more sources

Home - About - Disclaimer - Privacy